Axis USA Requires Vaccination For All New Employees And Many Existing Ones

Published Feb 14, 2022 12:39 PM

Vaccination mandates have become polarizing across the world and now they are impacting one of the industry's largest companies - Axis Communications.

IPVM Image

This was first reported on the SecurityVIP podcast, "Axis Communications Mandate Employees to be Vaccinated or suffer Termination."

However, Axis responded to IPVM with a detailed statement, acknowledging some elements but disputing the breadth and the severity of the policy.

Inside this note, we examine what is happening at Axis, how this is a growing problem for various companies, and how this could impact Axis.

For background, see An Inside Look into Axis Americas.

[Update: Report has been updated to include further information on impact for new Axis employees.]

Axis *********

**** **** **** *** ********* *********, copied, ** ****, *****:

**** **** *** ******* *********** *** all *********. ** *** ********,many ******** *** ******* ***********, ******** ******, *** ******** ****** ******* ***** ** ***********. We have decided to require *********** *** * ****** ****** of positions whose essential functions include participation in these types of activities.

******* *** ****** ** ** *** heart ** **** *******. ** ***** respect *** ********’* ******** ** *** be **********, *** ** ******** ** encourageemployees *** *** ** ******** ** ******** **** ********* ****** **** **** ** *** ******* ***********. [emphasis added]

**** *** *** ******* ** *** many ** ***** ********* ******* ***********.

Field *****

*** ***** **** ****** ** ** impacted *** ***** ** ***** ***** (i.e., ******** ***** ********, ******** *********** managers, ***** *********, ***.) ***** **** those ********* **** ********* ******* ******** travel ** ****** ** ********* **** may ******* ***** ** ***********.

**** *** ~*** *** *********, **** most ** **** ***** ** ***** roles, ****** ** *** *** ******* if **** *********** *********** ** *** every ***** ** ****** ***** ** regions ***** ***** *********** **** **** mandates.

ISC **** ** **** ********

**** *********** **** ******* **** *********** *** **** **** **** **** allows * ******** **** ********** * ******* ******** ******* ** being **********.

Difficulty ********* ****

***** **** ****** ********* ********* ** the ******* *********** ** ***** *** other ****, **** ** ****** ** be ********* *** ***** *********** ** try ** **** ** ****** ** inside ** ***** **** *** **** does *** ******* **** ******. **** if **** ***** (*.*., ****** ***** or **** *******), ***** ********* *** less *** *** *** ** **** the ********* **** ** **.

Medical / ********* *********

****** *********** ********* ** "****** ** to **** * ********* ** ******* exemption ** *** ***'** *** ******* vaccinated", **** *** *** ******* ** this.

Job *********** ********

***** **** ** *** ***** ******** manufacturer ** **** ***** **** **** a ***********, ** ***** **** * number ** ***** ************* *** ********* share *** ******* ***** ************ ********* job ***********. ******* ** *** ********** is ********** ** ************ *********, **** various ******* ********* ************ ** ** to ***********, ******, ***., *** ******* is **** ********* *** *** *** vaccinated **** ** ************ *** ****** to ** ***** ****, ***** * significant ******* ** ***** *** ******** being ** ***** ******.

Require ** *********** *********

******* ** ****' ******** ** "******[***] vaccination *** * ****** ****** ** positions", ********* ***** *** *** ***** terminating ********* ************ ** ***** *** performance *******, ******** ** ********** ** not ***** **** ** ** *** functions **** ******* ***********. ** ** possible **** ***-********** ********* ***** ***** approach ** *** **** ** ******** to ** ********** ******* ***** ** such ******.

Wait ***** ******** *** *******

******* ****** ** ** **** ***** mandates *** *******, ***** ***** *** steep **** ** ***** ***** *********, is ********* ********. **** *** ****** a ********* ***** ****** *** *** as ******** **** ****** ***** ******* cannot **** ** *** ***** *** to *** *********** ** *** ****'* vaccine ******* **********'* ******* ** ** **********. **** ******* (******) *** ******* **** ** ************ **** ****. **** *****, ***** Irving *** *** ********** *** *** more ******** **** *** ******** **** Axis **** **** ******.

Culture ******

**** **** ******* ********** ************** ** its *******, ***** ** ************ *** **** ************* ****:

****' ****** ****** ******* ** ***** personal ************* *** ******* ******... **** described *** ******* ** "****** ** none", **** ******** ****** ****** **** loved *** "***********" *** ***** *********** they ***** ** *** *******.

** *********** ************ **** **** ****** the **, **** ****** **** ***** risks *********** **** *******. *** ******* Axis ************ ** *** ******** ** competitor ********, **** ********* *** ******** to **** *** *** *****.

Product *********

**** ****** ***** ** * **** when**** ** ************** ****** ******* *********, *** *** *** **** ** a ***, **** ***** ** *** Pandemic.

***** ** *** ********** ****'* ******** with ********* ***** ***** **** ** locations **** ******* ********, **** ** risking ****-**** ****** ** ***** ******* now, **** ** **** ****** *** the ******* *********.

UPDATE *** *** ********* ******* *******

**** **** *** ******** *******:

**** ************** ***** ***** *** *********, their ********, *** *** ****** ** large ***requires *** *** ********* ** ** ***** ********** ** ******* *** ******* ** ******** ************* by their first day of work. All offers of employment are contingent upon proof of vaccination or approved requests for accommodation. [******** ******]

**** ********* ** **** ****:

**** ****** ******* ** *** *** employees ** *** ********. ** ***** of *********** ********* ** ** ******** for ******** ******* ** ******** ******, many ************ *** ***** ***** ** unable ** *********** ** **** ********** such ** ********* ********** ** ******—*** of ***** *** ** ********* **** of ************ *** *******.

** ********, **** ******* ********* ** IPVM **** **** *** ** ******* of ******** ******** **** *** **** to ******* **** ***********.

Comments (81)
JH
John Honovich
Feb 14, 2022
IPVM

***, ******* *** ********** ** ** that *****-** ************ *** ***** ******** in ******* *** *** ********. ** anyone ***** ** **** ******** *** ideally **** ** ** *******, ****** share.

Avatar
Daniel S-T
Feb 16, 2022

******** **********'* ** ******* ******** ****** are ********* ******** ** ** ********** to **** **********. ** ***** *** new ****, ** **** ***** ******** employees ***** *'* *** ******** *****.

***** ******* ********** ** *******

**** *** * *** ***** ********** jobs **** ******* ****** *** *******. Just ****** ******* ***** ******* *** my ****, *** ** *** *** it ****** ** *** *** ********, for ***********.

(1)
JH
John Honovich
Feb 16, 2022
IPVM

* **** ******* ***, *.*.,******** ******* **********, *** ** *** *** **** any **** *********** ***********:

IPVM Image

** ********** ** **** ****** *** tougher ** ******.

UI
Undisclosed Integrator #1
Feb 14, 2022

**** **** ******** ** ** ** issue *** ******* ******* **** ********** clients ***** ****** **** *** ** them ******* *** *********** ******** ***** property ** ** **********. ** **** seen ** ** * ******* ****** with ********** ******* - **** ******* vaccines, **** ***'*. **** ** * non-issue *** ** ***** * ** fully ********** *** ** **** * couple ** ***** *** *** *** and *** **** *** *** ******* to **** ** ******* *** *****. At **** **** ** **** ****** work *** *** **** **** ** projects **** ***'* ******* ************ *** that ****** ** ********** ** *** future.

(8)
U
Undisclosed #2
Feb 14, 2022

**** ** *** ** **** ******** have ******** *******, *****, *** ******* along **** ***** ***, *****, *** if *** **** ** *** ********, other ********. ****** **** * *********** policy *** ** ********* **** ***** socially *********** *** **** **** ******** sense. * ***** **** **** **** trouble ******* *** ***** ** ***** who *** ***.

(22)
(24)
(6)
(1)
UM
Undisclosed Manufacturer #3
Feb 14, 2022

******** **** *** **** ** ******* from * ****** ******* ** ***** up **** *********** ** *** ******* section.

(12)
JH
John Honovich
Feb 14, 2022
IPVM

* **** **** ** *** (********* other ******) * *****.

* ** ********* ***** *** *** been **** ****** **** ** ******'**** **** ***** ****'* ******** **** heated.

UM
Undisclosed Manufacturer #3
Feb 14, 2022

*********... ****...****...

(1)
UI
Undisclosed Integrator #1
Feb 14, 2022

*'* ***** ** ** *** ***** Bowl ***. ** ***** * ******* for ****?

(1)
(3)
UI
Undisclosed Integrator #9
Feb 15, 2022

***, ** * ***** *** *** you **** ***** **** ** ***** about *** ***** **** ***.

(1)
(6)
U
Undisclosed #6
Feb 14, 2022

*. **** ******* ** *** **** to ***-***********.

*. ****** *** ** **** ** losing ***** *** ** **** ***** up.

(1)
(1)
(1)
AB
Anthony Beland-Lavoie
Feb 16, 2022
IPVMU Certified

*** ** *** ******** *** ***** the *** *** *** **** **** Mr. ******* ****'* ********* **** ***** me ** ******* ** *** ******* up *** ******. ***** *** ****** anything *** ******* *** ***, **** pointing *** **** * ******* ** a **** ***** *** ********* ** his ******** *** *** ****** ** comments ** ****.

UI
Undisclosed Integrator #4
Feb 14, 2022

***** *** *** ****** ********. ********* a ******* ******* ** ***** ******** people ** ******** *** ******** * virus *******'* **** ** ****** * "vaccine". *** ********** *** ********** ******* are **** ******* *********** ***** ********** and ***** ******* ***** **** *** jab. *** ***, **** ** *** people *** ******* *** ******** ******, right?

(21)
(14)
(5)
U
Undisclosed #8
Feb 14, 2022

*** *** **** *** *-*-******** **-******?!

*** *******!

(12)
U
Undisclosed #13
Feb 23, 2022

***** *** *** ****** ********.

*** **** ** ***. ****'** ************.****'* why ** *** *.*. ****'** *** under ********* *** *************.

** **** **** ********, **** ***** not ******* ***.

(6)
(1)
UI
Undisclosed Integrator #14
Mar 01, 2022

****'** ************. ****'* *** ** *** U.S. ****'** *** ***** ********* *** Authorization.

*** ******* **** ****'* **** *** case ***, **, ***** *** **** eight ****** ** **?

*** ******** ***** *****-** ******* | FDA

(4)
(2)
UI
Undisclosed Integrator #18
Mar 22, 2022

* **** ****** ** **** * picture ** * **** ** ********* here ** *** ***, *** ***'*, it ***'* *********, *** **** **** deceived.

(3)
RS
Robert Shih
Feb 23, 2022
Independent

******** **** ***** ********* * ***** from ******** **** **** ********. **** just ****** **** **** ** ********* and ****** * ***** ******. ****** learn ******* ****** *** **** ********.

******** *** *** ******* *********** **** prevent ****** **** ******** **** ****. Masks *** ******* *** **** **** purpose. * *****, *** * ****** one ** *** **** ********* ** high ******.

(2)
(2)
U
Undisclosed #13
Feb 23, 2022

* *****, *** * ****** *** of *** **** ********* ** **** school.

***'** ****** ******* ***** **** ******* comments ********* *** *********** *********** ** other **** *******.

*************, **** ********** ** ************ ** your **** ** ************* ** *********** between **** ****** ******* *** ************/********.

*** ****** ****.

(1)
RS
Robert Shih
Feb 23, 2022
Independent

*****... *** *** ******* **** *******? "Differences" ******* ***** ******* *** *********** epidemiology *** *** ************* *** **** BUILD ** *** ********* **** ******** a ***** *** ********** ** ***** on *** **** *** ******* ******* in *** ***** *****. ** *****'* change *** ******* ** ***/***/**** ********. Do *** **** **** **** *** initial ****** **** * ***** ******* in **** * **** **** ***** it ********** *** * ******* (*** the ******** **** **** ******** **** it) ** ******* * ***** **********?

*****, ***'** *** ********* ** ******* to ****** ****** *** *** ********* to *** *****.

(1)
(1)
U
Undisclosed #13
Feb 23, 2022

*'* ********* ********* ** ********** *** I ****** ** ****** ** ************ vaccine *** *** **'* ********* ** prevent *** ********** *** ******* ******** from ********* ** ************** ****** *** those ** ** ******.

(2)
(4)
(1)
UI
Undisclosed Integrator #14
Mar 01, 2022

...**** ********** ** ************ ** **** lack ** ************* ** *********** ******* high ****** ******* *** ************/********. *** should ****.

******* *** ******** ** **** ****, I'd *** **** ********* ******* ** just ***** ******** ****. ******* "******** professional" ***** ** * ******* ****** to "**************/**********" *** **** ******'* *********.

(2)
(2)
U
Undisclosed #6
Feb 14, 2022

******, *** ******* *** ******* ******* released *** **** ******* * ***** of *.* ******* ******* ** ******* events ********* ***** ******** **** ********* between ***. **, ****, *** ***. 4, ****, ** *** ******* ******* Event ********* ****** (*****). ***** ** the ******* **********-****** ****** *** ********* adverse ******* ********* ** *** *.*.

**, ***, **** *********** [*******]. *** you ***’* **** * ***** **** during * ********…

********, ** *’* ***** ********** * can ***** *** ******* *** ****** it, **** ** ******* ******* ***? Not ********* ** *** ***. ******* is **** ******** ** *** *** to ** **% ** *** *****.

*** ***** **** **** ****** *** not ******* *** ***? ** **** zero ***** ** **** ***** ** the ********.

(15)
(8)
(2)
(2)
UI
Undisclosed Integrator #7
Feb 14, 2022

* **** **** ********** **** **** shots *** *** *******. * **** believe **’* * ******, *** * mandate *****.

**** ****, * **** *** *****-** for *** **** ****. *** **** threatening, *** *** * **** ** isolate, ** **** *** ****** ******** has ** ******* *** * *** emails *** **** ******** ***** **** steps.

** ***, *** *** ***** *** Covid ****** *** *** * ********* (or *** ** *****) ** *** Super **** *** *** * ********** telling ******** ** *** *** ***** and **** ** ** *** ***’* kill *******.

(22)
(4)
UM
Undisclosed Manufacturer #11
Feb 17, 2022

****** **** **** ********* **************. ***** is * ****** ********, ** *** controlled ** *********, *** ** ****-********. I ***** ********* ** ** ***** right *** *** ***** ** ******** as "** **** ********** ******* ***** I *** *** ***". *** ***** database ** ****** ** *** **********, but *** **** ******* ** ***** is **** ** ******* ** *** public, *** ******* ************. *** **** is *** ******** ** ********* ** any ***.

(5)
(5)
(2)
UM
Undisclosed Manufacturer #12
Feb 17, 2022

*** *** ********** ******* *** *** data? ******

(2)
(1)
(1)
UM
Undisclosed Manufacturer #11
Feb 17, 2022

***** ****?

U
Undisclosed #13
Feb 23, 2022

***** ** * ****** ********, ** not ********** ** *********,

**** *** ******* ***** ***** ***.

***** ** ******* ** *** *** and ***. ************, ********** ********* *** administer *****-** ******** ***required ** ***** ****** ** ***** ***, ***** the ******** ********* ******* ****** *** healthcare ********* *** ************ ** ***** ****** ** *****.

** ***** **** ******* *-* ***** to **** *** *****. ** *** think *** ******* *** ******* *** a ***** ** ******* ***'*, ***'** mistaken.

*** ***** ***** ** ***-******* **** leverage *** **** ********** **** *** their"***... ***.. ***... *** ** **** children ******** *******, *****, *** ******* along **** ***** ***, ***** ********... and ** *** **** ** *** military, ***** ********"******** (*** *****), *** **** *** data *****'* *** ***** *********, ***** is "**********".

IPVM Image

(2)
(1)
U
Undisclosed #13
Feb 23, 2022

******* ** **** ******** ** *** CDC ** ** **% ** *** cases.

*** *** ***** ** ** **** that *** ******** *** ****-***-* ********.

***** *** *******!!!

(2)
(1)
RS
Robert Shih
Feb 23, 2022
Independent

***** ****'* *** ***** ******* ***** that ************* *** ********. *******, ******* of *** ***** **** *** ********* can ** *** ***** *** ********** and **** ********** ****** **** *** analyzed ** ******** **** ***** ********* DNA *** **** **** *******. ********** additional ***** **** ****** ** * matter ** *********** **** ***** *** microscope.

*** ***'* *** ** ***** ********* on * ******* *** ****'* ****** to **** ************ ** ******.

(2)
U
Undisclosed #13
Feb 23, 2022

*** ***'* *** ** ***** ********* on * ******* *** ****'* ****** to **** ************ ** ******.

*** **** **** **** ************ ***** your *** *********. ****'* ***** "*'* smarter **** ***" ******** ***** (** far).

(1)
RS
Robert Shih
Feb 23, 2022
Independent

* *** **** *****, ******* *** keep ********** ** ******** **** *** are ************** ** **** ****** *****.

(2)
U
Undisclosed #13
Feb 23, 2022

********** ********** ***** **** ****** ** a ****** ** *********** **** ***** the **********.

*** **** **** * *******, ***** were ** *********** ******** ** *** self-administered *****. *** ***, ** **** be *****, ** *******, *****?

RS
Robert Shih
Feb 23, 2022
Independent

****-************ ***** *** **** ******* ********* RAPID *****. ***** **** ** **** and ******* ********* ** ********* ***** a ************* ********** ******* ** **** strains *** ******* ** ***** *****. Math, *** *** **** **? *** you ****** ** **** **********?

(1)
U
Undisclosed #13
Feb 23, 2022

****, *** *** **** **? *** you ****** ** **** **********?

*** *** ****** **** ********?

RS
Robert Shih
Feb 23, 2022
Independent

**, *'* ***** ** ********** ****** questioning *******. **** **** ** **** people *** ******** **** *** ************ and ********** ** ***** ***** ********** fields **** *** "***********" ******'* ** bothered ** ***** ******** ********** *** come ** **** *** *********** ** the *****.

(1)
(1)
U
Undisclosed #13
Feb 23, 2022

**, *'* ***** ** ********** ****** questioning *******.

***'** *** ** *******. ***** ** contain ********.

RS
Robert Shih
Feb 23, 2022
Independent

***'** ***** ******* *** ********* ************ disinformation **** *** ***** ******** *** you **** ** ** ******* ******? That's ****.

UI
Undisclosed Integrator #14
Mar 01, 2022

******, *** ******* *** ******* ******* released *** **** ******* * ***** of *.* ******* ******* ** ******* events ********* ***** ********

***, * **** *** ******* ********* to *** ***** ** ** ***** (all ***** *******, ***). ** ******** was **** *** * ****** ** days, *** *** *** ****** ***, my ***** *** *** * *** sore *** *****-******* *** *** ****** day.

** **** *****, *** ******** *** "bad" ******* **** ****** **** *** have **** **** ******, **** ******** "adverse ********".

(2)
(2)
(2)
U
Undisclosed #13
Feb 23, 2022

**** ** *** ** **** ******** have ******** *******, *****, *** ******* along **** ***** ***, *****, *** if *** **** ** *** ********, other ********.

**, **** ***** ************ ****?

(2)
RS
Robert Shih
Feb 23, 2022
Independent

***** ******** **** **** ************ ********** and ****. *** ******** ** *** contrary *** ****** ** *** ***** of ************** ****-*******.

(1)
U
Undisclosed #13
Feb 23, 2022

***** ******** **** **** ************ ********** and ****

******** ** ****?

RS
Robert Shih
Feb 23, 2022
Independent

******** ** *** ********* *** ***** have *******? ******** ** **** ***** still *******?

************ *********** *** *********** ******** ****** the ***** **** ******** ** ***** within ******. **** ******* ********* ** in **** **** *** **** ******** as ****-***** ******, ****-******* ******, ***.

(1)
U
Undisclosed #13
Feb 23, 2022

** *** **** **** ** ******** related ** ***** ********?

(1)
RS
Robert Shih
Feb 23, 2022
Independent

*** **** **** *** ** ***** of * **** ******** ** *** Cutter ********. ********** **** *** ***** that ******** **** **** ******* ****** improve ** ******** *** ****** ***** the ***** ****.

U
Undisclosed #13
Feb 23, 2022

*** **** **** ***

** ***** *** ********** **** ******** and ***** *** ********* *****.

(1)
(1)
U
Undisclosed #5
Feb 23, 2022

IPVM Image

(1)
(1)
U
Undisclosed #5
Feb 14, 2022

******** ****: "******** ******** *** ******** To ******* **** ********"

IPVM Image

(8)
(1)
(4)
(28)
JH
John Honovich
Feb 14, 2022
IPVM

UPDATE *** *** ********* ******* *******

**** **** *** ******** *******:

**** ************** ***** ***** *** *********, their ********, *** *** ****** ** large ***requires *** *** ********* ** ** ***** ********** ** ******* *** ******* ** ******** ************* by their first day of work. All offers of employment are contingent upon proof of vaccination or approved requests for accommodation. [******** ******]

**** ********* ** **** ****:

**** ****** ******* ** *** *** employees ** *** ********. ** ***** of *********** ********* ** ** ******** for ******** ******* ** ******** ******, many ************ *** ***** ***** ** unable ** *********** ** **** ********** such ** ********* ********** ** ******—*** of ***** *** ** ********* **** of ************ *** *******.

** ********, **** ******* ********* ** IPVM **** **** *** ** ******* of ******** ******** **** *** **** to ******* **** ***********.

(4)
UI
Undisclosed Integrator #9
Feb 14, 2022

****** **** ** ** **** ** brush ** *** *** ******. ** an ******** ***** ******* */* *** out ** *** ******* * **** the ****.

(3)
(2)
(9)
JH
John Honovich
Feb 14, 2022
IPVM

*****! "******, * ** ******** *** very **** ** ** *** *** don't ****** **** ***** **** **** but * ** ***** **********...."

(1)
(1)
(1)
(13)
UI
Undisclosed Integrator #9
Feb 15, 2022

"******, * ** ******** *** **** good ** ** *** *** ***'* really **** ***** **** **** *** I ** ***** **********...."

* *** ** ********** ** ***** wonderful.

(10)
U
Undisclosed #13
Feb 23, 2022

** ** ******** ***** ******* */* are *** ** *** ******* * like *** ****.

***** *** ****** **** ********* *** medical **********... **** ****.

JH
John Honovich
Feb 15, 2022
IPVM

******** ***********:

IPVM Image

**** ** *** **** ******* ** see ****** ***** *******-******* **** ***** the ******* *** ********* **** *********** groups *** ******* *** ****** **** relatively *** ***** *******.

(1)
(3)
JH
John Honovich
Feb 15, 2022
IPVM

*******, **** ** ********'* "*********" ****** found **** * *** ***********:

Vaccine ***********

******** ********* *** *********** * ********* COVID-19 *********** ******. ** ******** ********* all ********* ** ** ***** **********. Any ******** *** ** *** ********** must **** * **** ** *** times **** ** * ******** ********* site ** ********* ******* **** ***** Motorola ********* ********* ** *********. ********* who **** ********* ***** ** *********** must ****** ****-******** ** ***** **** requirements. ************, ******* ***** *********** ** Motorola *********' ********* *** **** ******* requirements **** ***** ** **** ** our *********.

(3)
(1)
Avatar
Pauli Wanker
Feb 16, 2022
Aviscon KG/SAS

** **** ******* **** *** **** parts ** **** ***** ****** ** request (******, ******** ....) ** *** can * *** *** ****** ******* if ****** *** ***** ** ** company **** ** ***** *** *** the ****** ** *** **** ** to **** *** ***? * *** to **********....

(10)
(2)
(2)
(3)
U
Undisclosed #13
Feb 23, 2022

** *** *** * *** *** driver ******* ** ****** *** ***** in ** ******* **** ** ***** but *** *** ****** ** *** need ** ** **** *** ***?

**'* *** *** ****. ****** ** being ****** ** *** * ******'* license **** ********* ***** **** ** myocarditis, ***** *****, ** ******* (**** to **** * ***).

Avatar
Pauli Wanker
Feb 23, 2022
Aviscon KG/SAS

* **** ******* ****** *** **** in *** ********* *** **** *** died ******* ** ***********. *************, * lot ** ****** *** ** *** accidents ***** **** ******* **** **** wearing *********, ** **** *** *** drive ******* ********* ** ** *** number ** ****** ***** ******* ** seatbelts ******* **** *********?

(1)
UI
Undisclosed Integrator #7
Feb 23, 2022

** **** *****. ****, ***** ** the ****** ** ******* ****** **** year ** ****** **** ********* ****.

(1)
(1)
U
Undisclosed #13
Feb 23, 2022

********* ***'* ******** *** **** ** myocarditis, ***** *****, ** ******* ******.

(1)
(1)
Avatar
Rusty Crocker
Feb 16, 2022

**** ** ** ****** *** ***!

(2)
(1)
(1)
UI
Undisclosed Integrator #10
Feb 17, 2022

*** ***** *** **** ****** **** times **** ****. **** *** ** FAR *** ***** ** *** ** lead ***** **** ** **** ****.

(4)
(3)
U
Undisclosed #2
Feb 23, 2022

***'* ***, ** *** ** ****, and ** *** **** ** *** Physical ******** *********. ** **** **** Risk. **** **********. ** ***** **** vs. ****** ** **** **. *******. Ever *** *** *** ****? ** is ********* ** ******** **** *** reduce ********. *****'* ******* *** ***, but ********* *** ********. ********** *** period ** ********* *** ***** **********. = **** **** ** ******...

******** *** ******** ******** **** ***** the *** *** *****. *** *** report * ******** ** * **** effect, ** *** *** * ***** or ***** ******* ***-****-*********** ******. ** that ****** * ****** ** ** an *****? ** ******, ***** **** always ** * **** ***** ********** that *** ****** ******** *** **** is ****** *********** *** ***.

** ** **** **** ***** ***** is ********* ********* ** *** **** the *******.

**** ** ***** **** **. ****** comes **** ****. *** ******* ****. I ** ** *******'* ******.. ** you **** ***** *** ******* **** it **** *** ***** ** ***. Such ***** *********.

*** ***** ** *** ********* *********. All **** **** **** ****. ******* you **** ** **** ****** *******, Tylenol, **** ******, *** * **** of ***** ******** ***-***-***** ****, *** you ****'* *** ***'*. **** * convenient ******.

*** ******** *** *** **** ******* up *** **** ******** ** *** hospital ****, **** ****** ** ** about *** **** ****** **** ***** the *****. * ********* ****** ** Darwin ******...

**** ******** ******* **** ** *** tip ** **** ****.***** ****, *** *** ******** **** ignorance *** ********* ** ******. **** contagious ***** ** ****** ** * biological ******.

(7)
(3)
(1)
(2)
RS
Robert Shih
Feb 23, 2022
Independent

**** ** * ********* *********.

(3)
(2)
(2)
U
Undisclosed #13
Feb 23, 2022

*** ***** ** *** ********* *********. All **** **** **** ****.

** ***'** ****-************? *** ***'* ******* others' ********* *******?

** **** **** ***** ******** *** Christianity, **** **** ***** *** ** allowed ****.

************.

(1)
(2)
(3)
UI
Undisclosed Integrator #9
Feb 24, 2022

* ********* ****** ** ****** ******...

**********: ** ** ********* **** *****.

****** ***** ******* **** ******* ********* occurred. ** ******* *** ******* **** then ******* ********* ** ****** *******.

(1)
(3)
U
Undisclosed #13
Mar 01, 2022

*** ***** ** *** ********* *********. All **** **** **** ****. ******* you **** ** **** ****** *******, Tylenol, **** ******, *** * **** of ***** ******** ***-***-***** ****, *** you ****'* *** ***'*. **** * convenient ******.

********* *********? *'** **** **** **** of *** ***** ******** **** ** religious ********* ******, ******* ** ** attorney *** **.

***** **** ***** **** *** **** in ***-******* ******** ***** *** ***-****’*. Most *********** ** *** ******** ************* used ** ********* ** ********* ********* were ********, ****, *** ******** *** their ******* ******** **** ****** ***** cell ***** **** **** ** ********** research.

******* ***** ******** ******* (*** **), Hydroxychloroquine (****), ************* (****), ********** (****), SudafedAcetylsalicylic **** (***) (****), ******* (****), Pepto ****** (****), **-*** (****), *********/********** (1922), ************* (****), **** (****), *** Preparation * (****).

*** ********* ****** ***** *** ********** to ******** ********** ** *** ************ vaccines ** **** *** ************* ********* in **** **** *** ******* *** ethically *************.

***** **** ***** *** *** ** primary *********, *** ** ** *** of ****. ** ******* ********* ** vaccine ************ **** *** ******** ** the ***** ****** ******.

* **** ******* ** ** ******* for ****** ** *** ******** ** violate ***********, *********** ********** ****** ** human ******* *** ******* ** ****** regarding ****, ******, *** ****-*****.

(3)
(2)
(1)
U
Undisclosed #13
Mar 01, 2022

** *** ***, ** ************** **** granted. ** ****'* ************** **** **** granted.

*** ***'* ****** *** **** ******. Parents **** *** ** ******** ** take *** ***** ** ******* ******* school, ******* **** *** **** ***** stronger **** ******* ***** **** ** money.

(1)
JH
John Honovich
Mar 21, 2022
IPVM

******,** **** ******** ********** *********:

IPVM Image

IPVM Image

IPVM Image

IPVM Image

(3)
UI
Undisclosed Integrator #9
Mar 21, 2022

** **** ****** ***** ***** ****** here ** *** **** **** ***** this *********** ** **** *********? * am ******** ** ****** ** *** Venn ******* ** ***** ** * circle.

* ** *** **** **. ********* and **** ** *** * ********* on *** ************.

JH
John Honovich
Mar 21, 2022
IPVM

*****'* **** **** ******* ***** ******* Axis ** ***** **** ** *** employees *** * ***'* ***** ****'* the ****. ***, ****'* * ***** disruptive *** ** ** ***** ***** this ***, **** *** *** ******* shortage *****, **** ** *** * company ** *******.

UM
Undisclosed Manufacturer #15
Mar 21, 2022

******** ** ** ******** ******** *** pro-vax / ****-******* - *** *** a ****** *** ** ****. ** only *** ***** *** ** ****** on, **'* *** *** ****** *** chance ** *************** *** ***** ** certain ******-*********** ** ***** ******. ****’* not *******, *** **********, ***** *** also ******** ***** ** *** ******** causing ******* ************* *** ***** ** a ***** % ** ***** **********.

* ******* ***** *** ***’* **** to *** ********** *** ***’* ******* they ****** ** ********** **** ******* or **** ***** **********. ******* ****** or ****** ** ** ****** *** in ***** ****** **** **********. ** they ****, **’* **** ***** ***********, including ********* **** ********* *********, ****** than *** *** **** ** ******** to ******* ****

(2)
(1)
U
Undisclosed #16
Mar 22, 2022

***** ********* ** ****, *** ** will ****** * ****** ******** *****. Especially *** **** ** *** ******** that ********** ******** **** ** ****** going *******. **** ***** ** ***** additional ******** **** *** ** * employment ***********? ********* **** ***** **** vaccination ************ ********* ******, *** ***? One ********* **** ** *** ********** for ***** *******, *** *** ***** have ***** **** * ********** ***********. What ***** ***** **** **** ***-******** conditions **** *** *** **** ** be ********** ** **** **** ***** personal ******? **** ***** ** *** argument **** ** ** *** **** protection *** *** ********** ** ******. This ** *** ****** **** ****, as ** *** **** **** *** vaccinations **** ****** ******** **** ******** and *** **** *** ******* ************. So, *** **** ********* *** ******** to ******* ***** ************ (*** **** own **** *** ******), **** ******** them **** ********* ***** ****** ******** like ****** *** ************ ** ********** requirement? **** *** **** ** ** is **** ***** **** * ****** flu ***********, ******* *** *********** ** one ***** ******** **** *** ***. What ***** *******? ** *** **** that ******* ** * ****** **** to ******** *** ****** (*** **** smoke). *** ********* *** **** **** non-smoking ** ********** ***********? *** ** this ***** ** **?

** *** **** ********. ********** **** masks *** *** *** ********* ** transmission ** ********** *** ********** ** water ******* ********* **** *** ******* COVID-19. **** ** *** ****** ********* as *** *****-** ********* *** **** smaller **** *** **** **** ******. If ******** ***** ******** *** ******** in *** *** **** ***, *** will ******* **** ** **** ** no ****. ** ******* * **** gives *** ***** ** ****, **** you *** ***** **** **** ** reducing *** ******, **** **** ***. But, ***'* ***** **** ******* ** is * ********** ***** **** ******* the *****.

*****, *****-** ** **** ** ****, Like ***** ******* **** *******, ** will ******** ** ****** ** ***** variants ** ** **** **** ** learn ** **** **** **. *** vaccinated/boosted ** *** **** **** ** is *** **** ***** ** ********** and ******** *** *********'* ********. **** a ****, ** *** **** ** that ** **** ***** ****** *** spread. ** **** ** *** **** that ** *** **** ****** ** action. *** * **** ***** ********* are ******** *** ****** *** ** an ********** ** ********** *********** ** mandate.

(2)
(2)
UI
Undisclosed Integrator #17
Mar 22, 2022

****** ******* *** * ***? ***** are ****** ****** ** ****. **** of **** ***** *** **** ******.

UI
Undisclosed Integrator #18
Mar 22, 2022

***** ******* ** **** ****** ** severe ******* *** ***** ** **** promised, ** ****, ** ** ****** now.

(1)
(1)
U
Undisclosed #13
Mar 23, 2022

IPVM Image

(2)
U
Undisclosed #19
Mar 23, 2022

** ******* *** **** *** ******** most ** ***** ******** *** ****** companies ** *** ********* ** *** US, ********** **** *** ****** ** what ** **** ** *** ************* companies, *** ***** ********* ************, * have **** **** ****** *** ******** have **** **** * *********, ***********, and ******** ************ *****, **** ***** companies. **** ** ***** ********* ** my **** **** **** ***** **-**% of ***** ***** *** *** ********** I **** **** ** ** **** to. *** ***** *** *** ****** transitioning **** ******* ** ** ****** to ******* **** ****, ** *** job ****** ** *** ******** *** loaded **** **** ********* *** ******* for ******* ********* ** **** ***** someone *** **** **** ** **** all *** *** ****** *********.

***** ** *** ** ********** **** just ******* * ********* ******* ******* that ** *** **** ** **** to ** ***** **** ** *** current ********* * **** **** **** got *** *** *** ** **** to *** * ******* ** ****** to *** * ******* *** **** ever *******, **** **** ** *** now ***** ** ******** ** *** customer *** ***** **** *** ****** the ***** ** * ******** ** will ***** ** ** **...

** *** **** * **** **** the **** ** *** *** ****** or ********* ********* *** *** ****** proficient ** ***** *** *** **** the ***** ******* **** *** ***, "you **** **** * **** *** enough ** **** ********, * **** take * *** ** ** ******** of ****** ** *** *** ** with **** **** ******* ** ** and ** ** *** *****". ** what ******* ** ***** ***** ********* lose ***** ***** *** **** **** to *********** *** *** *** **** part ** ** **** *** *** Vaxxed *** **** **** *** ** preform *** **** ******.

* **** **** ****** ********* ****** lately *** **** **** *** **** the ** **** * ***** **** never ***** **** ****** ****** *** this ***** **** ******** *** ** thee ***** ******** * ******* *** why, "** **** *** ** ** vaxxed ( *** ***** *******) ** be ******** ** ***** ** **** job." **** ** ** ** *** as ** ***** **** ***** ** convince ** ** *** *** *** to **** **** **** ** **** are **** *********.

** *** ** ***** *** **** see ***** ***** ********* ***** ** fold **** **** **** **** **** restaurants **** **** *** ***** ********. Axis ******* **** **** ****** ** answer ********* *** *** *** **** ride **** **** ***** *** ** long, (**** **** *****) ****** ***** move ** ** ***** ********...

******** ****** **** ********** ***, *** just *** *** **** **** **** looks ****....

(3)
(3)
(1)
UI
Undisclosed Integrator #17
Mar 23, 2022

**** * **** ** ***** ** perform ******* ** * **********, ***** have * **** ***** ** * was **********. *******, *** ** *********, temperature ******, **** *** **** ****** was **** ** *** *******. *** nursing **** *** ** *** * hazmat ****! ** *** **** *** not ******** ** ****, * *** scolded (******* ** * ********) *** told * *** ** **** ** properly.

**** ******* * ****** ********* *** you **** *** *** *** ****** dicktators ***.

*** * *** ** ** ***** at ***** *** **** *** **** scam, *** **** ******* *** ***** victims. ******* ***** *********, *********, *******, visitors. *** ** *** ***** ****** - *** ** ** ******* * lot ** *** ********** **** ** will **** ******* ** **.

(2)
(1)
(3)
UI
Undisclosed Integrator #20
Mar 24, 2022

***, *** **** ** ** *** group **** **** *** *** ******* around *** ***** *** **** *** flat. ***** ******* ****. *** ******** think ******* ** **** ***. **** a ***** ****.

(2)
(2)
(2)
(1)
U
Undisclosed #8
Mar 24, 2022

*****~******* ****** **** ****** ***** ** in ****~***~******** ***** ** *** *** ******** ineffective **** *******~*******~********* ******* *** **********, ********** ****, more **** *********** **** *****~

(1)
(1)
(1)
(1)
UI
Undisclosed Integrator #17
Mar 23, 2022

** **. ***********, **** ** **** your **** **** *** *******.